1. Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis. Issue 2 (27th October 2016) Authors: El Raziky, M.; Gamil, M.; Ashour, M. K.; Sameea, E. A.; Doss, W.; Hamada, Y.; Van Dooren, G.; DeMasi, R.; Keim, S.; Lonjon‐Domanec, I.; Hammad, R.; Hashim, M. S.; Hassany, M.; Waked, I. Journal: Journal of viral hepatitis Issue: Volume 24:Issue 2(2017) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗